IGF-IR in human head and neck cancer.

Slides:



Advertisements
Similar presentations
Enhanced DNA damage in IDH1 mutant glioma cells.
Advertisements

Rab11-FIP3 silencing upregulates TCR-CD3 cell surface expression in an Lck-dependent manner. Rab11-FIP3 silencing upregulates TCR-CD3 cell surface expression.
MEL23 and MEL24 inhibit Mdm2 and p53 ubiquitination in cells.
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.
Collagen-dependent phosphorylation of eIF4E in PDAC cells.
Effect of Nf1 knockdown on Wnt pathway in MSC80 cells.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Downregulation of caveolin-1 by si-RNA in NIH3T3 cells increased survivin expression. Downregulation of caveolin-1 by si-RNA in NIH3T3 cells increased.
Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
Cell viability assay and expression of COX protein.
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined.
FOXO3a phosphorylation and expression.
SiRNA screening identifies genes required for the viability of Pim1-ovexpressing prostate cells. siRNA screening identifies genes required for the viability.
FAK overexpression in invasive human breast cancer and DCIS
Protein expression profile in a dasatinib-resistant cell line.
Expression of FGF2, IGF-1R, and IR in melanoma cells compared with normal melanocytes. Expression of FGF2, IGF-1R, and IR in melanoma cells compared with.
Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells. Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells.
CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection of CXCR4 siRNAs. CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection.
VEGF expression in neoplastic and normal prostate tissue.
A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.
A, TSG-6 staining in TRAMP tissue and TRAMP cell lines.
MiR-200c is a PI3K–AKT signaling pathway regulator in CRC
Expression of CRC stem cell markers and L1 in CRC cells.
Knockdown of PKM2 suppressed TPA-induced skin cell transformation.
A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety of 24 human cell lines. A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety.
TFAP2A knockdown inhibits cell growth by targeting HIF-1α signaling.
Expression pattern of TLR-4 and MyD88 in EOC cells.
Activation of mTOR signaling (increased phosphorylated S6 ribosomal protein) and loss of inhibition of IRS-1 in human endometrial carcinomas. Activation.
Gamma camera images at 72 h of patient with T3N0M0 squamous cell cancer of the tongue base (patient 14). Gamma camera images at 72 h of patient with T3N0M0.
PAP- and PA2024-specific CTLs at week 0 (prior to sipuleucel-T infusion) and at weeks 6 and 26 post–sipuleucel-T treatment. PAP- and PA2024-specific CTLs.
Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs.
A, Western blot analysis of vascular endothelial growth factor-C (VEGF-C). A, Western blot analysis of vascular endothelial growth factor-C (VEGF-C). Concentrated.
SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.
Effects of HDAC2 inactivation on the invasive potential of human gastric cancer cells. Effects of HDAC2 inactivation on the invasive potential of human.
Gamma camera images at 72 h of patient with T4N2M1 ductal breast cancer (patient 6). Gamma camera images at 72 h of patient with T4N2M1 ductal breast cancer.
Isolation of stable XPAKD and XPCKD HeLa clones.
The effects of HDAC2 knockdown on cell-cycle proteins.
Reduced klotho expression in pancreatic cancer.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Tivantinib does not inhibit MET function.
ODC protein expression in paired benign and cancer tissue obtained from patients with PCA. The protein expression was measured by immunoblot analysis in.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.
Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and HAL-treated xenografts. Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and.
Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter. Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter.
The best response for target lesions per patient for patients with target lesions assessed at baseline and at least 1 follow-up. The best response for.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
SAHA blocks IR-induced increase of RAD51 protein in MM cells.
A, TSG-6 staining in human prostate.
Effect of bevacizumab on the proliferation of A2780 cells.
Levels and activity of c-myc are increased in a series of stably transfected DAOY and UW228 medulloblastoma cell lines. Levels and activity of c-myc are.
HOXA11-AS acts as a ceRNA for miR-1297.
Decreased dopamine uptake following downregulation of SLC6A3.
Interaction of NHEJ and HR pathways in PCO cultures.
MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.
Posttranslational phosphorylation of p53 by platinum drugs in ovarian tumor cells. Posttranslational phosphorylation of p53 by platinum drugs in ovarian.
PARP1 suppresses the transcription of PD-L1 in cancer cells.
T-cell expression of second-generation CARs
Expression of chemokine receptors in A-498 cell line.
CPGL is a growth suppressor in pancreatic cancer cell lines.
Cell counts of immune infiltrate and expression of galectin-1 and galectin-3 in the short-, medium-, and long-term survival cohorts. Cell counts of immune.
Effects of NMT siRNAs on MARCKS and c-Src.
miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.
Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.
Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.
TCTP enhances the protein stability of Pim-3 by blocking the ubiquitin–proteasome degradation of Pim-3. TCTP enhances the protein stability of Pim-3 by.
Presentation transcript:

IGF-IR in human head and neck cancer. IGF-IR in human head and neck cancer. A, Western blot analysis of IGF-IR and vinculin (as a loading control) in SCCHN cell lines. Western blot analysis (B) and scanning densitometry ratios (C) of IGF-IR and vinculin expression in paired normal and tumor tissue from tongue cancer patients. D, control nonspecific (NS) or IGF-IR–specific siRNA was transiently transfected into 183A cells and protein expression was assessed 3 d later by Western blot. E, 183A or TU159 cells were transiently transfected with control (nonspecific) or IGF-IR–specific siRNA and total cell counts were assessed 3 d later. *, P < 0.05, different from normal tissue (C) and the cell line–specific control group (E). Christopher J. Barnes et al. Clin Cancer Res 2007;13:4291-4299 ©2007 by American Association for Cancer Research